Effectiveness of erlotinib against recurrent pulmonary adenocarcinoma unresponsive to gefitinib: Report of a case

Fumihiro Shoji, Daigo Kawano, Kensaku Ito, Yosuke Morodomi, Tokujiro Yano, Yoshihiko Maehara

Research output: Contribution to journalArticlepeer-review

2 Citations (Scopus)

Abstract

We report a case of recurrent pulmonary adenocarcinoma, found 2 years after resection, which responded extremely well to erlotinib, after gefitinib treatment had failed to evoke any response. This case report provides useful information for thoracic oncologists and shows that we should consider giving erlotinib after gefitinib for recurrent pulmonary adenocarcinoma, even if the gefitinib treatment is ineffective.

Original languageEnglish
Pages (from-to)255-257
Number of pages3
JournalSurgery today
Volume41
Issue number2
DOIs
Publication statusPublished - Feb 2011

All Science Journal Classification (ASJC) codes

  • Surgery

Fingerprint

Dive into the research topics of 'Effectiveness of erlotinib against recurrent pulmonary adenocarcinoma unresponsive to gefitinib: Report of a case'. Together they form a unique fingerprint.

Cite this